6.26
Arcturus Therapeutics Holdings Inc 주식(ARCT)의 최신 뉴스
Responsive Playbooks and the ARCT Inflection - news.stocktradersdaily.com
What drives Arcturus Therapeutics Holdings Inc stock priceLow Beta Stocks & Free Trend Following Techniques - earlytimes.in
Arcturus Therapeutics Hits 52-Week Low at $5.85 Amid Financial Struggles - Markets Mojo
Is Arcturus Therapeutics Holdings Inc. stock a safe haven assetJuly 2025 Closing Moves & Stepwise Entry and Exit Trade Signals - newser.com
Balyasny Asset Management L.P. Increases Stake in Arcturus Thera - GuruFocus
Arcturus Therapeutics Hits 52-Week Low at $6.02 Amid Major Decline - Markets Mojo
Is Arcturus Therapeutics Holdings Inc. stock ready for a breakoutJuly 2025 Review & Technical Buy Zone Confirmation - newser.com
What candlestick patterns are forming on Arcturus Therapeutics Holdings Inc. - newser.com
Can Arcturus Therapeutics Holdings Inc. stock beat market expectations this quarterJuly 2025 Analyst Calls & Fast Entry High Yield Tips - newser.com
Can momentum traders help lift Arcturus Therapeutics Holdings Inc.2025 Performance Recap & Detailed Earnings Play Strategies - newser.com
How Arcturus Therapeutics Holdings Inc. stock responds to policy changesNew Guidance & AI Powered Market Trend Analysis - newser.com
Arcturus Therapeutics Hits 52-Week Low at $6.72 Amid Ongoing Struggles - Markets Mojo
Arcturus Therapeutics Hits 52-Week Low at $7.26 Amid Financial Struggles - Markets Mojo
Arcturus Therapeutics Holdings (ARCT) Price Target Decreased by 28.26% to 32.77 - MSN
How to forecast Arcturus Therapeutics Holdings Inc. trends using time series2025 Price Momentum & Verified Trade Idea Suggestions - newser.com
How currency fluctuations impact Arcturus Therapeutics Holdings Inc. stockJuly 2025 Breakouts & Free Verified High Yield Trade Plans - newser.com
Wall Street Zen Upgrades Arcturus Therapeutics (NASDAQ:ARCT) to “Hold” - Defense World
Published on: 2025-11-15 17:06:19 - newser.com
What technical models suggest about Arcturus Therapeutics Holdings Inc.’s comeback2025 Market Outlook & Momentum Based Trading Signals - newser.com
Arcturus Therapeutics Holdings Inc. stock volume spike explained2025 EndofYear Setup & High Accuracy Trade Alerts - newser.com
Arcturus Therapeutics Hits New 52-Week Low at $7.76 - Markets Mojo
What is William Blair’s Forecast for ARCT FY2025 Earnings? - Defense World
How to use a screener to detect Arcturus Therapeutics Holdings Inc. breakoutsJuly 2025 Recap & Precise Swing Trade Alerts - newser.com
Citigroup Maintains Arcturus Therapeutics Holdings (ARCT) Neutral Recommendation - Nasdaq
Arcturus outlines 12-week cystic fibrosis study launch in 2026 amid cost controls and delayed KOSTAIVE BLA - MSN
ARCT: Citigroup Adjusts Price Target and Maintains Neutral Ratin - GuruFocus
Arcturus cut to Neutral at Citi on data for mRNA candidate - MSN
Is Arcturus Therapeutics Holdings Inc. stock cheap at current valuation2025 Technical Patterns & Real-Time Volume Analysis Alerts - newser.com
What MACD signals say about Arcturus Therapeutics Holdings Inc.Rate Hike & AI Powered Buy and Sell Recommendations - newser.com
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q3 2025 Earnings Call Transcript - Insider Monkey
Arcturus Therapeutics Holdings Inc. SEC 10-Q Report - TradingView
[10-Q] Arcturus Therapeutics Holdings Inc. Quarterly Earnings Report | ARCT SEC FilingForm 10-Q - Stock Titan
ARCT: HC Wainwright & Co. Lowers Price Target, Maintains Neutral Rating | ARCT Stock News - GuruFocus
Understanding the Setup: (ARCT) and Scalable Risk - news.stocktradersdaily.com
Piper Sandler Maintains Arcturus Therapeutics Holdings (ARCT) Overweight Recommendation - Nasdaq
Arcturus Therapeutics (ARCT) Target Price Significantly Lowered by Piper Sandler | ARCT Stock News - GuruFocus
자본화:
|
볼륨(24시간):